small molecule

NALMEFENE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyKNOA →See this company's full patent-cliff portfolio

Drug detail

Brand name	NALMEFENE HYDROCHLORIDE
Active ingredient	NALMEFENE HYDROCHLORIDE
Strength	EQ 2MG BASE/2ML (EQ 1MG BASE/ML)
Dosage form	SOLUTION
Route	INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Modality	Small molecule
FDA approval	February 2022
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.